Novartis

NVS

Börsenwert 287 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
776	776 Bedel Financial Consulting Indianapolis, Indiana	677.971 $	-53.369 $	-356	-8 %
777	777 First City Capital Management Savannah, Georgia	673.531 $	-3.448 $	-23	-0,5 %
778	778 Aspiriant LLC Los Angeles, California	672.329 $	+208.678 $	+1.392	+48 %
779	779 Clear Harbor Asset Management Stamford, Connecticut	669.665 $	-13.342 $	-89	-2 %
780	780 Anchyra Partners Atlanta, Georgia	668.411 $	+14.242 $	+95	+2 %
781	781 Cambient Family Office Ada, Michigan	668.254 $	–	–	–
782	782 RNC Capital Management Los Angeles, California	667.784 $	-35.379 $	-236	-5 %
783	783 Mill Capital Management Concord, North Carolina	659.008 $	-27.434 $	-183	-4 %
784	784 L.J. Altfest & Co New York	657.060 $	+62.513 $	+417	+11 %
785	785 WesBanco Bank Wheeling, West Virginia	656.812 $	-11.093 $	-74	-2 %
786	786 Greenspring Advisors Towson, Maryland	653.979 $	-83.951 $	-560	-12 %
787	787 PFG Investments Woodbury, New York	653.940 $	+10.794 $	+72	+2 %
788	MA 788 Mutual Advisors Omaha, Nebraska	652.971 $	+58.616 $	+391	+10 %
789	789 Convergence Financial Columbia, Missouri	651.014 $	-77.355 $	-516	-11 %
790	PWAM 790 Pinnacle West Asset Management Casper, Wyoming	651.000 $	–	–	–
791	791 CreativeOne Wealth Overland Park, Kansas	647.483 $	+100.291 $	+669	+19 %
792	CH 792 Cromwell Holdings Jackson, Wyoming	645.216 $	–	–	–
793	793 Thornburg Investment Management Santa Fe, New Mexico	644.746 $	–	–	–
794	794 First Command Advisory Services Fort Worth, Texas	643.806 $	+455.883 $	+3.041	+285 %
795	795 Advisor OS Chicago, Illinois	642.936 $	-31.182 $	-208	-5 %
796	796 Optas LLC Austin, Texas	642.238 $	+37.328 $	+249	+6 %
797	797 Baker Tilly Wealth Management Madison, Wisconsin	642.082 $	-19.489 $	-130	-3 %
798	798 Argyle Capital Partners Los Angeles, California	641.612 $	–	–	–
799	799 Capital Analysts LLC Fort Washington, Pennsylvania	638.000 $	–	–	–
800	800 IFP Advisors Tampa, Florida	637.537 $	+58.316 $	+389	+11 %

Novartis NVS Börsenwert 287 Mrd. $

Novartis

NVS

Börsenwert 287 Mrd. $